3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 1/2
7
Phase 1
5
Phase 3
3
Phase 2/3
2
Phase NA
1
Phase EARLY_PHASE1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
15
Stomach Neoplasms
11
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Rectal Neoplasms
4
Pancreatic Neoplasms
3
Neoplasms
3
Biliary Tract Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Adenocarcinoma
2
Vipoma
1
Somatostatinoma
1
Resected Liver Metastases From Colorectal Cancer
1
Recurrence
1
Quality of Life
1
Pathologic Complete Response
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Neoplasms
1
Insulinoma
1
Immunotherapy Gastrict Cancer
1
HER2-positive Gastric Cancer
1
Glucagonoma
1
Gastroesophageal Junction Adenocarcinoma
1
Gastrinoma
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Fluorouracil
3
Docetaxel
3
Oxaliplatin
2
Leucovorin
2
trametinib
1
milk-thistle extract
1
halofantrine
1
dabrafenib
1
Ursodeoxycholic Acid
1
Silymarin
1
Nadroparin
1
Irinotecan
1
Heparin, Low-Molecular-Weight
1
Drug Therapy
1
Cisplatin
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Gastrointestinal Neoplasms
×
Oxaliplatin
×
Clear all
NCT06028737
2025-05-06
OCTASUR
Ukrainian Society of Clinical Oncology
Phase 2/3
Recruiting
150 enrolled
NCT04393584
2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3
Unknown
538 enrolled